How to Reduce Swelling from Thyroid Eye Disease

Swelling from thyroid eye disease (TED) comes from inflammation deep behind your eyes, and reducing it requires a combination of daily habits, medical treatment, and in some cases surgery. The approach depends on whether your disease is in its active inflammatory phase or has stabilized. Most people see the worst swelling during the first one to three years, and the strategies that help range from simple changes at home to targeted medications that can shrink swollen tissue by more than a third.

What Causes the Swelling

The puffiness, bulging, and eyelid swelling in TED aren’t caused by the thyroid itself. They’re driven by inflammation behind the eye, where immune cells mistakenly attack the tissue surrounding your eye muscles. Specialized cells in the eye socket called orbital fibroblasts become overactive, producing large amounts of a water-attracting molecule that pulls fluid into the tissue. At the same time, immune cells flood the area, causing the eye muscles to swell and fat tissue to expand. This combination pushes the eyes forward (proptosis) and creates the visible puffiness in the eyelids and surrounding skin.

Doctors track this inflammation using a Clinical Activity Score, which assigns points for specific signs: eyelid swelling, eyelid redness, redness over the white of the eye, and swelling of the clear membrane covering the eye. A higher score means the disease is more active, and that distinction matters because active disease responds to anti-inflammatory treatment while inactive, burned-out disease typically requires surgical correction.

Daily Habits That Reduce Puffiness

Some of the most effective steps you can take at home target the fluid retention that makes morning swelling especially bad. When you lie flat, fluid pools in the soft tissue around your eyes. Sleeping with your head elevated lets that fluid drain downward overnight. The University of Michigan Health recommends propping the head of your bed up by placing bricks under the bed frame, rather than just stacking pillows, which can shift during the night and strain your neck.

Reducing salt in your diet also helps. Sodium causes your body to hold onto water, and that extra fluid worsens tissue edema around the eyes. You don’t need to follow a rigid diet plan. Simply cutting back on processed foods, canned soups, and restaurant meals can make a noticeable difference in how puffy your eyes look day to day. Cool compresses applied to the eyelids in the morning can also temporarily reduce swelling by constricting blood vessels in the area.

Why Quitting Smoking Matters

If you smoke, stopping is the single most impactful lifestyle change you can make for TED. Smoking doesn’t just raise the risk of developing thyroid eye disease. It makes existing disease worse and harder to treat. Across multiple studies, current smokers were consistently more likely to experience disease progression and respond poorly to treatment. Case-control studies found that smoking increased the odds of developing TED by anywhere from two to twenty times compared to nonsmokers. Three out of four studies tracking patients over time confirmed that smokers had worse outcomes than those who quit or never smoked.

Selenium for Mild Disease

For mild TED, selenium supplementation is one of the few over-the-counter options with clinical evidence behind it. A landmark randomized trial found that six months of selenium supplementation significantly slowed disease progression and improved quality of life in people with mild thyroid eye disease. The dosage used in clinical trials is 100 micrograms of sodium selenite taken twice daily (200 micrograms total per day). Patients in that trial saw meaningful improvements in their quality-of-life scores, with a positive response defined as at least a six-point improvement on a standardized scale.

Selenium works as an antioxidant and may help calm the immune overactivity behind the eyes. It’s worth noting that this benefit has been demonstrated primarily in mild cases. If your swelling is moderate or severe, selenium alone is unlikely to be enough, though it may still be a useful addition to other treatments.

Steroid Treatment for Active Swelling

When TED is moderate to severe and actively inflamed, intravenous steroids are the standard first-line treatment. The most common approach involves weekly infusions over 12 weeks, with a total cumulative dose of about 4.5 grams. This regimen significantly reduces the Clinical Activity Score (the inflammation rating) and improves quality of life while keeping side effects relatively low compared to higher doses.

Some treatment protocols use a more intensive schedule, with infusions on consecutive days over shorter periods, but the 12-week weekly regimen has the strongest evidence. Studies comparing six-week and 12-week courses found that the longer course produced significantly better improvements in inflammation scores. Oral steroids are sometimes used but carry more side effects than the intravenous pulse approach, which delivers high doses directly while limiting the total amount your body absorbs over time.

Targeted Therapy With Teprotumumab

Teprotumumab (sold as Tepezza) is a newer treatment that works differently from steroids. Instead of broadly suppressing inflammation, it blocks a specific receptor on the orbital fibroblasts that drives the tissue expansion behind the eyes. The results from clinical trials published in the New England Journal of Medicine were striking: 83% of patients treated with teprotumumab achieved a meaningful reduction in eye bulging (at least 2 millimeters) at 24 weeks, compared to just 10% of those receiving a placebo.

Imaging from the trial showed the treatment physically shrank the swollen tissue. Six patients who underwent orbital scans before and after treatment had an average 35% decrease in eye muscle volume, along with reductions in orbital fat. The treatment is given as an intravenous infusion every three weeks for a total of eight infusions. It’s approved for active TED and represents a significant advance for people whose swelling doesn’t respond well to steroids, though it comes with a high cost and potential side effects including hearing changes and elevated blood sugar.

Surgery for Persistent Swelling

Once TED has been stable and inactive for at least six months, surgery becomes an option for swelling and bulging that medical treatment didn’t fully resolve. The key principle is timing: orbital decompression surgery works best in the inactive phase, after inflammation has burned out. Operating during active disease risks unpredictable outcomes because the tissue is still changing.

The exception is when swelling compresses the optic nerve and threatens vision. In those cases, decompression can be performed urgently even during active disease if steroids haven’t relieved the pressure.

For planned, rehabilitative surgery, the specific approach depends on how much your eyes bulge and whether you have double vision. For mild bulging, surgeons often remove orbital fat to create more space. For moderate to severe bulging, bone is removed from the walls of the eye socket to allow swollen tissue to expand into the surrounding sinus cavities. In the most severe cases, three walls of the orbit may be opened. Eyelid surgery and eye muscle surgery for double vision are typically done afterward, in a specific sequence: decompression first, then muscle alignment, then eyelid correction.

Controlling Thyroid Levels

Keeping your thyroid hormone levels stable plays a supporting role in managing TED swelling. Fluctuations in thyroid function, whether too high or too low, can trigger flares of orbital inflammation. Working with your endocrinologist to maintain consistent thyroid levels won’t eliminate the eye disease on its own, but it removes one of the factors that can make swelling worse. This is especially important after radioactive iodine treatment for Graves’ disease, which can temporarily worsen TED if thyroid levels aren’t carefully managed during the transition.

Putting It All Together

The right combination depends on where you are in the disease. During the active phase, when your eyes are red, swollen, and changing, the priority is controlling inflammation with medical treatment while supporting recovery through sleep elevation, salt reduction, and not smoking. For mild active disease, selenium may be enough. For moderate to severe active disease, intravenous steroids or teprotumumab can produce significant reductions in swelling. Once the disease stabilizes, surgical options can address whatever bulging or puffiness remains. Most people with TED use several of these strategies at different stages, and the swelling does improve with time and treatment.